Molecular model of firmonertinib (IMAGE)
Caption
Molecular modeling illustrates how firmonertinib, depicted in magenta, binds to PACC-mutant EGFR proteins.
Credit
The University of Texas MD Anderson Cancer Center
Usage Restrictions
N/A
License
Original content